Koers Sareum Holdings Plc CINNOBER BOAT
Aandelen
SAR
GB00B02RFS12
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 55K 69,95K 64,36K | Omzet 2025 * | - | Marktkapitalisatie | 33,19 mln. 42,21 mln. 38,84 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -3 mln. -3,82 mln. -3,51 mln. | Nettowinst (verlies) 2025 * | -2 mln. -2,54 mln. -2,34 mln. | EV/omzet 2024 * | 630 x |
Nettoschuld 2024 * | 1,45 mln. 1,85 mln. 1,7 mln. | Nettoschuld 2025 * | 2,08 mln. 2,65 mln. 2,44 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-6,52
x | K/w-verhouding 2025 * |
-8,47
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,98% |
Recentste transcriptie over Sareum Holdings Plc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Reader
FOU | Founder | 56 | 01-08-03 |
Timothy Mitchell
FOU | Founder | 63 | 01-08-03 |
Clive Birch
BRD | Director/Board Member | 70 | 13-11-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Parker
CHM | Chairman | 65 | 17-05-16 |
Timothy Mitchell
FOU | Founder | 63 | 01-08-03 |
Clive Birch
BRD | Director/Board Member | 70 | 13-11-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,58% | 115 mld. | |
+12,41% | 107 mld. | |
-3,44% | 21,6 mld. | |
-12,38% | 22,31 mld. | |
-6,82% | 19,19 mld. | |
-3,35% | 18,23 mld. | |
-38,57% | 17,62 mld. | |
+7,51% | 14,26 mld. | |
+35,67% | 12,37 mld. |